Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

Molecular and Cellular Endocrinology
Louise M BilezikjianWylie Vale

Abstract

Activins are multifunctional proteins and members of the TGF-β superfamily. Activins are expressed locally in most tissues and, analogous to the actions of other members of this large family of pleiotropic factors, play prominent roles in the regulation of diverse biological processes in both differentiated and embryonic stem cells. They have an essential role in maintaining tissue homeostasis in the adult and are known to contribute to the developmental programs in the embryo. Activins are further implicated in the growth and metastasis of tumor cells. Through distinct modes of action, inhibins and follistatins function as antagonists of activin and several other TGF-β family members, including a subset of BMPs/GDFs, and modulate cellular responses and the signaling cascades downstream of these ligands. In the pituitary, the activin pathway is known to regulate key aspects of gonadotrope functions and also exert effects on other pituitary cell types. As in other tissues, activin is produced locally by pituitary cells and acts locally by exerting cell-type specific actions on gonadotropes. These local actions of activin on gonadotropes are modulated by the autocrine/paracrine actions of locally secreted follistatin and by the f...Continue Reading

References

Mar 1, 1991·Endocrinology·K KogawaH Sugino
Oct 1, 1991·Proceedings of the Society for Experimental Biology and Medicine·L V DePaoloN Ling
Nov 30, 1990·Biochemical and Biophysical Research Communications·U MichelJ K Findlay
Feb 1, 1990·Molecular Endocrinology·N BillestrupW Vale
Nov 30, 1989·Biochemical and Biophysical Research Communications·D Gospodarowicz, K Lau
Nov 30, 1988·Biochemical and Biophysical Research Communications·M KitaokaE Ogata
Apr 29, 1988·Biochemical and Biophysical Research Communications·S ShimasakiN Ling
Jan 1, 1995·Annual Review of Physiology·T K Woodruff, J P Mather
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·M M MatzukA Bradley
Feb 1, 1993·Molecular and Cellular Endocrinology·U MichelJ K Findlay
Mar 1, 1993·Molecular and Cellular Endocrinology·K Miyanaga, S Shimasaki
Jun 1, 1993·The Journal of Clinical Investigation·U B Kaiser, W W Chin
Jul 1, 1993·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·B L LeeG Childs
Apr 1, 1996·The Journal of Clinical Endocrinology and Metabolism·P J IllingworthW J Bremner
Apr 1, 1997·Proceedings of the Society for Experimental Biology and Medicine·L V DePaolo
Feb 7, 1998·The Journal of Biological Chemistry·L B DraperT K Woodruff
May 30, 1998·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·A ShimizuK Miyazono
Jun 17, 1998·Genes & Development·M TreierM G Rosenfeld
Nov 4, 1998·Frontiers in Neuroendocrinology·D J Phillips, D M de Kretser
Dec 29, 1998·Cell·R DerynckX H Feng
Jan 19, 1999·Molecular Endocrinology·J J LebrunW Vale
Jul 20, 1999·Molecular and Cellular Endocrinology·E SeuntjensC Denef
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·C KioussiM G Rosenfeld
Feb 9, 2000·Trends in Biochemical Sciences·P ten DijkeC H Heldin
Feb 24, 2000·Biology of Reproduction·B L BohnsackN B Schwartz
Mar 10, 2000·Cytokine & Growth Factor Reviews·J L Wrana, L Attisano
Mar 14, 2000·Current Opinion in Cell Biology·L Attisano, J L Wrana

❮ Previous
Next ❯

Citations

Oct 23, 2013·Molecular and Cellular Endocrinology·Finn-Arne WeltzienTrude M Haug
Jun 7, 2016·Molecular and Cellular Endocrinology·Jakob Schiøler Hansen, Peter Plomgaard
May 9, 2015·PloS One·Maria K Herndon, John H Nilson
Apr 1, 2016·Scientific Reports·Ghislaine GarrelJoëlle Cohen-Tannoudji
Mar 27, 2018·Endocrinology·T Rajendra Kumar
Jan 24, 2014·Endocrine Reviews·Kyriaki S AlatzoglouMehul T Dattani
Dec 7, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jérôme FortinDaniel J Bernard
Jul 15, 2016·Cold Spring Harbor Perspectives in Biology·Chenbei Chang
Jul 1, 2012·Hormones : International Journal of Endocrinology and Metabolism·Menelaos L Batrinos
Jul 1, 2017·The Journal of Biological Chemistry·Brian C GohDouglas J DiGirolamo
Dec 20, 2014·The Journal of Biological Chemistry·Huizhen WangT Rajendra Kumar
May 22, 2018·Best Practice & Research. Clinical Endocrinology & Metabolism·Sara Babcock GilbertT Rajendra Kumar
Jun 11, 2021·Endocrinology·Tal Refael, Philippa Melamed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Related Papers

Reproduction : the Official Journal of the Society for the Study of Fertility
Louise M BilezikjianWylie Vale
Trends in Endocrinology and Metabolism : TEM
Craig A HarrisonDavid M Robertson
Molecular and Cellular Endocrinology
Varykina G ThackrayDjurdjica Coss
© 2022 Meta ULC. All rights reserved